Q3 2015 Holdings
Filed 2015-11-16 | 19 holdings | $32.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $16.9M | 1,411,567 | 52.0% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $14.6M | 1,516,387 | 45.1% |
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $294.1K | 2,979,100 | 0.9% |
| Ophthotech Corp | COM | 683745103 | $199.0K | 4,910,487 | 0.6% |
| Inogen Inc(INGN) | COM | 45780L104 | $172.3K | 3,549,320 | 0.5% |
| Vanguard Intl Equity Index F(VGK) | FTSE EUROPE ETF | 922042874 | $103.3K | 2,101,000 | 0.3% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $29.0K | 625,704 | 0.1% |
| Tobira Therapeutics Inc | COM | 88883P101 | $26.0K | 2,696,405 | 0.1% |
| Wright Medical Group | CONTINGENT VALUE RIGHTS | 98235T115 | $20.9K | $4,622,032 | 0.1% |
| Otonomy Inc | COM | 68906L105 | $15.6K | 875,025 | 0.0% |
| Flexion Therapeutics Inc | COM | 33938J106 | $15.4K | 1,033,131 | 0.0% |
| Tokai Pharmaceuticals Inc | COM | 88907J107 | $12.8K | 1,238,252 | 0.0% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $11.8K | 3,056,563 | 0.0% |
| Invuity Inc | COM | 46187J106 | $11.0K | 787,282 | 0.0% |
| HTG Molecular Diagnostics Inc | COM | 40434H104 | $9.8K | 1,280,185 | 0.0% |
| Nabriva Therapeutics AG | COM | 62957M104 | $8.2K | 867,127 | 0.0% |
| Penumbra, Inc.(PEN) | COM | 70975L107 | $4.2K | 104,944 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $1.8K | 75,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.1K | 127,563 | 0.0% |